Literature DB >> 23372179

Extreme hyperferritinaemia; clinical causes.

Martin A Crook1, Patrick L C Walker.   

Abstract

There are many causes of raised serum ferritin concentrations including iron overload, inflammation and liver disease to name but a few examples. Cases of extreme hyperferritinaemia (serum ferritin concentration equal to or greater than 10 000 ug/l) are being reported in laboratories but the causes of this are unclear. We conducted an audit study to explore this further. Extreme hyperferritinaemia was rare with only 0.08% of ferritin requests displaying this. The main causes of extreme hyperferritinaemia included multiple blood transfusions, malignant disease, hepatic disease and suspected Still's disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23372179     DOI: 10.1136/jclinpath-2012-201090

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  [Relationship between marked hyperferritinemia and hemophagocytic lymphohistiocytosis].

Authors:  W B Gao; M J Shi; H Y Zhang; C B Wu; J H Zhu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-18

2.  Severe Human Granulocytic Anaplasmosis With Significantly Elevated Ferritin Levels in an Immunocompetent Host in Pennsylvania: A Case Report.

Authors:  Mona L Camacci; Ronaldo Paolo Panganiban; Zachary Pattison; Kamyar Haghayeghi; Alexander Daly; Cindy Ojevwe; Ryan J Munyon
Journal:  J Investig Med High Impact Case Rep       Date:  2018-02-13

3.  Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents.

Authors:  John Scott Baird
Journal:  Int J Inflam       Date:  2022-03-22

Review 4.  Hyperferritinemia-A Clinical Overview.

Authors:  Miriam Sandnes; Rune J Ulvik; Marta Vorland; Håkon Reikvam
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

5.  Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience.

Authors:  Döndü Üsküdar Cansu; Hava Üsküdar Teke; Güven Barış Cansu; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2021-07-02       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.